COMMUNIQUÉS West-GlobeNewswire

Financière de Tubize SA : Buy-back of own shares
01/12/2018
FINANCIERE DE TUBIZE SA/NV Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, general manager, aspijcke@icloud.com Buy-back of own shares Regulated information 1 st December 2018 The board of directors [...]
Financière de Tubize SA : Rachat d'actions propres
01/12/2018
FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, aspijcke@icloud.com Rachat d'actions propres Information réglementée 1 er décembre 2018 Le Conseil d'administration de [...]
Cooper Hotel Receives ConventionSouth’s Annual Readers’ Choice Award
01/12/2018
Cooper Hotel recognized for commitment to professionalism, creativity and service DALLAS, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Cooper Hotel is honored to accept the ConventionSouth 2018 Readers’ Choice Award. This is the [...]
Canopy Growth and Canopy Rivers Announce Completion of TerrAscend Restructuring
01/12/2018
TORONTO, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (“ Canopy Growth ”) and Canopy Rivers Inc. (“ Canopy Rivers ”) (TSXV: RIV) are pleased to announce the closing of the [...]
Exergen Global’s Sensors Help Smisson-Cartledge Biomedical (SCB) Develop a Solution to Ensure Safe Blood Transfusions With Reliable, Accurate Temperature Measurement
01/12/2018
Exergen Global Joins with SCB to help it Conquer Complexity in Building Fluid Infusion Systems that Maintain Precise Temperatures of Blood Products WATERTOWN, Mass. and ZIJTAART, the Netherlands, Nov. 30, 2018 (GLOBE [...]
Altimmune Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01/12/2018
GAITHERSBURG, Md., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (NASDAQ: ALT), a clinical-stage immunotherapeutics company, granted equity awards on November 30, 2018, that were previously approved by the [...]
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/12/2018
CAMBRIDGE, Mass., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, granted equity awards on November 30, 2018, that were previously [...]
Tetra Bio-Pharma Closes Financing With Aphria Inc.
30/11/2018
With increased cash Tetra will ramp up Drug Development Activities ORLEANS, Ontario, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc (“ Tetra ” or “ TBP ”), (TSX VENTURE: TBP) (OTCQB: TBPMF), has closed a private [...]
QIAGEN and NeoGenomics collaborate to offer cancer patients Day-One access to innovative companion diagnostics for newly approved drugs
30/11/2018
Partners discuss efforts to accelerate precision medicine solutions at ASH 2018 HILDEN, Germany and GERMANTOWN, Md. and FORT MYERS, Fla., Nov. 30, 2018 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime [...]
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
30/11/2018
Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 29 November 2017 and on 7 September 2018, issued convertible loans with total nominal amount of MSEK 28 and MSEK 35.2 respectively. In total circa [...]
Akari Therapeutics Announces New Data Highlighting Differentiation of Drug Candidate Coversin
30/11/2018
Planned introduction of patient-friendly pen auto-injector in 2019 designed to increase comfort and convenience of treatment across the entire Akari subcutaneous program Second eculizumab-resistant patient with [...]
Share issue / transfer and annulment of shares in connection with the reduction of the quantity of shares in Nexstim Plc
30/11/2018
Company announcement, Helsinki, 30 November 2018 at 17:30 Share issue / transfer and annulment of shares in connection with the reduction of the quantity of shares in Nexstim Plc The Extraordinary General Meeting of [...]
Olainfarm increases profitability and earns 7.5 million euros in nine months
30/11/2018
Unaudited consolidated Income Statement of JSC Olainfarm for nine months of 2018 shows that the sales of the Group have reached 89.5 million euros, which is a slight decrease by 1% compared to the same period of 2017. [...]
JSC Olainfarm Strengthens the Boards of Several Daughter Companies
30/11/2018
Board of JSC Olainfarm has decided to make some changes to Management Boards of Silvanols LLC, Latvijas Aptieka LLC and Tonus Elast LLC. Larisa Podlesnaja has left the Management Board of Tonus Elast to continue in [...]
Coherus BioSciences Announces Apexus Contract Agreement for 340B Hospitals and Clinics, and Q-Code Issuance from CMS
30/11/2018
REDWOOD CITY, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that the company has executed a 340B prime vendor program contract agreement with Apexus, LLC. Apexus is [...]
HEXO scoops two prizes at 2018 Canadian Cannabis Awards
30/11/2018
GATINEAU, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO) was honoured for product innovation with two prestigious Canadian Cannabis Awards at the 2018 gala. Hydropothecary by [...]
HEXO remporte deux prix aux Canadian Cannabis Awards 2018
30/11/2018
GATINEAU, Québec, 30 nov. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX:HEXO ) a été honoré pour l'innovation de ses produits avec deux prestigieux prix canadiens du cannabis lors du gala de 2018 [...]
Clementia Announces the Departure of Chief Commercial Officer
30/11/2018
MONTREAL, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage biopharmaceutical company innovating treatments for people with ultra-rare bone disorders and other diseases, [...]
Clementia annonce le départ de son chef de la direction commerciale
30/11/2018
MONTRÉAL, 30 nov. 2018 (GLOBE NEWSWIRE) -- Clementia Pharmaceuticals Inc. (Nasdaq : CMTA), une société biopharmaceutique au stade clinique proposant des traitements novateurs pour les personnes atteintes de troubles [...]

Pages